Skip to search formSkip to main contentSkip to account menu

cetamolol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Epinephrine-induced hypokalemia is a beta 2-adrenoceptor-mediated effect known to occur in patients after acute myocardial… 
1988
1988
The objective of the present study was to compare the quantitative differences in the β1,- vs. β2-adrenoceptor affinity and… 
1988
1988
The effect of cetamolol (an investigational cardioselective beta blocker with intrinsic sympathomimetic activity) on the… 
1986
1986
We studied blood pressure (BP) and heart rate (HR) responses in 12 patients with hypertension who were receiving cetamolol, a… 
1985
1985
Cetamolol is a new beta-adrenoceptor blocking agent shown in animals to have moderate beta 1-adrenoceptor selectivity and partial… 
1985
1985
The cardiovascular effects of adimolol, a new, potent, long acting beta-adrenoceptor blocking drug were investigated in three… 
1984
1984
The cardiovascular effects of cetamolol, a new beta-adrenoceptor blocker, were studied in the anesthetized dog and cat and in the… 
1984
1984
Cetamolol, a new beta-adrenoceptor blocker with partial agonist activity and cardioselectivity, was studied in vivo to determine… 
1983
1983
In vitro studies on the new beta-adrenoceptor antagonist, cetamolol (Betacor), have demonstrated that the compound is a potent… 
1983
1983
  • J. Jaramillo
  • Canadian journal of physiology and pharmacology
  • 1983
  • Corpus ID: 25294947
The effects of cetamolol (AI-27,303, Betacor), atenolol, propranolol, and dexpropranolol were evaluated in 36 chloralose-urethane…